Comprehensive medication guide to Zenpep including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$30–$200 per month depending on insurance tier; most commercial plans cover Zenpep at Tier 2–4. The Z-Save® manufacturer program reduces costs to as low as $0 for the first fill and $30 for refills for eligible commercially insured patients.
Estimated Cash Pricing
$235–$2,490 per 100 capsules depending on strength (3,000–60,000 lipase units); the most common 40,000-unit strength runs $1,525–$2,280 at retail. GoodRx or SingleCare coupons may reduce cost by 20–30%.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Zenpep (pancrelipase) is a brand-name prescription medication used to treat exocrine pancreatic insufficiency (EPI) — a condition in which the pancreas cannot produce or deliver enough digestive enzymes to properly break down food. It was first approved by the FDA in 2009 and is currently marketed by Nestlé Health Science through Aimmune Therapeutics, Inc.
Zenpep contains three classes of porcine-derived digestive enzymes — lipase, protease, and amylase — in enteric-coated delayed-release capsules. The enteric coating protects the enzymes from stomach acid, allowing them to activate in the small intestine where digestion of nutrients occurs. Zenpep is available in eight dose strengths ranging from 3,000 to 60,000 lipase units per capsule.
EPI can result from cystic fibrosis, chronic pancreatitis, pancreatic cancer surgery (pancreatectomy), or other conditions affecting the pancreas. Without enzyme replacement, patients experience severe malabsorption, steatorrhea (oily stools), weight loss, and dangerous nutritional deficiencies. Zenpep is not a controlled substance and is not interchangeable with other pancrelipase products — each PERT product requires its own prescription.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Zenpep replaces the digestive enzymes that a healthy pancreas would normally produce and secrete into the small intestine. When taken with a meal, Zenpep's enteric-coated beads pass through the stomach intact (protected from stomach acid by their pH-sensitive coating) and dissolve in the alkaline environment of the duodenum and proximal small intestine (approximately pH 5.5 or above).
Once released, Zenpep's lipase hydrolyzes dietary fats into monoglycerides and free fatty acids; its proteases break down proteins into peptides and amino acids; and its amylase converts starches and carbohydrates into dextrins and short-chain sugars. These forms are then absorbed through the intestinal wall in the same way as normal digestion.
Pancrelipase is minimally absorbed into the bloodstream and works entirely within the gastrointestinal tract. It is not a substrate of CYP enzymes or drug transporters, which explains why Zenpep has very few traditional drug-drug interactions. Because the enzymes must be present in the intestine simultaneously with food, Zenpep must be taken at the beginning of every meal and snack.
3,000 lipase units — delayed-release capsule
Lowest available strength; used for infants and low-dose titration
5,000 lipase units — delayed-release capsule
Low-dose option for small children or low fat intake
10,000 lipase units — delayed-release capsule
Common pediatric starting dose
15,000 lipase units — delayed-release capsule
Mid-range pediatric or adult maintenance dose
20,000 lipase units — delayed-release capsule
Common adult maintenance dose
25,000 lipase units — delayed-release capsule
Mid-high adult dose
40,000 lipase units — delayed-release capsule
Higher-dose adult strength for significant fat malabsorption
60,000 lipase units — delayed-release capsule
Highest available strength; for high-fat-intake adults or severe EPI
Zenpep is not on the FDA's national Drug Shortage Database as of 2026, but localized availability problems are common. Because Zenpep is a brand-only medication with no generic substitute, pharmacies must stock the specific branded product in up to eight different dose strengths. Not every pharmacy carries every strength, and smaller or rural pharmacies may stock only the most commonly prescribed doses.
High per-patient consumption (patients may use 90–180+ capsules per month) means pharmacies can exhaust their stock quickly. The porcine-based manufacturing process adds complexity that limits production redundancy. Patients who use less common dose strengths (such as 3,000, 5,000, 15,000, or 25,000 units) may experience the most frequent availability gaps.
If your pharmacy is out of Zenpep, medfinder can call pharmacies near you to identify which ones have your specific Zenpep strength in stock, saving you hours of phone calls. You can also ask your pharmacy to place a special order (typically arriving in 1–2 business days) or contact a specialty pharmacy for more consistent supply.
Zenpep is not a controlled substance and carries no DEA scheduling restrictions. Any licensed prescriber in the United States can write a prescription for Zenpep. The most common prescribers are:
Telehealth visits are appropriate for established EPI patients managing ongoing Zenpep therapy, dose adjustments, and PERT product changes. Initial EPI diagnosis typically requires in-person evaluation with laboratory testing and imaging. Many GI practices and primary care providers now offer telehealth follow-up for stable EPI management.
No. Zenpep (pancrelipase) is not a controlled substance and has no DEA scheduling. It can be prescribed by any licensed healthcare provider, including primary care physicians, gastroenterologists, pulmonologists, nurse practitioners, and physician assistants. There are no federal restrictions on the number of refills, and prescriptions can be sent electronically or by phone to any pharmacy.
While Zenpep is not controlled, your insurance plan may impose its own quantity limits or require prior authorization to confirm that your diagnosis (EPI due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions) qualifies for coverage. If your insurance requires prior authorization, ask your prescriber to submit one with your diagnosis documentation.
The most commonly reported side effects in clinical trials (occurring in ≥6% of patients) include:
Know what you need? Skip the search.
Creon (pancrelipase)
Most widely prescribed PERT in the U.S.; AbbVie; enteric-coated microspheres; 6 strengths (3,000–60,000 units); approved for CF, chronic pancreatitis, pancreatectomy. Clinical data shows non-inferiority to Zenpep in fat absorption.
Pancreaze (pancrelipase)
Enteric-coated microtablets; approved for CF and other EPI conditions; multiple strengths; brand-only like Zenpep.
Pertzye (pancrelipase)
Bicarbonate-buffered enteric microspheres; may help patients with low duodenal pH; approved for CF and other conditions.
Viokace (pancrelipase)
Non-enteric-coated tablet; must be taken with proton pump inhibitor (PPI); approved for adults only with EPI due to chronic pancreatitis or pancreatectomy.
Prefer Zenpep? We can find it.
Acarbose (Precose)
minorTheoretical interaction: amylase in Zenpep may counteract acarbose's mechanism of blocking carbohydrate digestion. Not confirmed in clinical studies but worth mentioning to your doctor if you take both.
Miglitol (Glyset)
minorSame theoretical amylase interaction as acarbose. Rarely a clinical concern as EPI patients seldom take alpha-glucosidase inhibitors. Discuss with your prescriber.
Proton pump inhibitors (PPIs)
minorNot an adverse interaction — PPIs (omeprazole, pantoprazole, etc.) can actually support Zenpep effectiveness by reducing gastric acid. Sometimes co-prescribed to optimize enzyme delivery.
Porcine protein allergy
majorNot a drug interaction but a critical safety consideration: patients with known allergy to porcine proteins face elevated risk of allergic reaction to Zenpep, which is derived from pig pancreatic glands.
Zenpep is a proven, FDA-approved treatment for exocrine pancreatic insufficiency that helps patients with cystic fibrosis, chronic pancreatitis, and other conditions maintain normal digestion and nutritional health. When taken correctly — with every meal and snack, at the right dose — Zenpep dramatically improves quality of life for EPI patients. The key challenges patients face are access and cost, not efficacy.
On the access front, Zenpep's brand-only status and multiple dose strengths mean pharmacy availability requires active management. Refill early, maintain a list of pharmacies that carry your dose, and consider mail-order for more reliable supply. The Z-Save® manufacturer savings program offers significant cost relief for commercially insured patients — enroll if you haven't already.
If your pharmacy is out of stock, medfinder can help you find Zenpep at nearby pharmacies quickly, without spending hours on hold. You provide your medication and location; medfinder calls pharmacies and texts you results.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards